Printer Friendly

COPLEY PHARMACEUTICAL, INC. ANNOUNCES ESTIMATED ALBUTEROL RECALL EXPENSES

 CANTON, Mass., Jan. 5 /PRNewswire/ -- As previously announced, Copley Pharmaceutical, Inc. (NASDAQ: CPLY) is voluntarily recalling all lots of its 20 milliliter vials of Albuterol Sulfate Inhalation Solution, 0.5 percent due to microbial contamination (e.g., Pseudomonas fluorescens) discovered in certain manufacturing lots during Copley's routine quality assurance procedures. The recall does not affect the Albuterol Sulfate Inhalation Solution, 0.083 percent product manufactured by Copley.
 Copley currently estimates that its out-of-pocket expenses for the recall will be approximately $6 million which will be incurred over the current and next fiscal quarters. Copley will not resume shipping of its 20 milliliter vials of Albuterol Sulfate Inhalation Solution, 0.5 percent until after manufacturing validation has been completed. Copley's sales of Albuterol Sulfate Inhalation Solution, 0.5 percent are significant to its operations. For the fiscal year ended Jan. 31, 1993, Copley's net sales of autonomic drugs, which include Albuterol Sulfate Inhalation Solution, 0.5 percent, represented 14.1 percent of total net sales.
 Copley Pharmaceutical, Inc. is a leading manufacturer and marketer of a broad range of off-patent prescription and over-the-counter pharmaceuticals in a variety of dosages.
 -0- 1/5/94
 /CONTACT: Steven N. Tannenbaum of Copley Pharmaceutical, Inc., 800-325-6111/
 (CPLY)


CO: Copley Pharmaceutical, Inc. ST: Massachusetts IN: MTC SU:

CK -- NY088 -- 9558 01/05/94 19:24 EST
COPYRIGHT 1994 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1994 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 5, 1994
Words:220
Previous Article:JCPENNEY SALES UP 13.7 PERCENT IN NOVEMBER
Next Article:MOTHERS WORK, INC. ANNOUNCES NOVEMBER SALES
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters